Testing light therapy with CPAP in people with depression and sleep apnea
Tests light therapy alongside CPAP use in adults with depression and sleep apnea.
Plain-language title generated from the registry record
Registry title: Combining Light Therapy and CPAP in Depression
Key facts
- Where
- Bron, FranceSee the site
Where in France
- Centre Hospitalier Le VinatierBron, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hôpital le Vinatier
- Trial code
- NCT06781593
- Record updated
- 29 April 2025
- Original description
In a double-blind, parallel-group controlled trial, we aim to measure the effect of two weeks of light therapy combined with the CPAP on compliance CPAP in patients with major depressive disorder.Read full original descriptionShow less
Effects of Light Therapy on Compliance With Continuous Positive Airway Pressure in a Population of Depressed Patients Newly Fitted With Devices for Obstructive Sleep Apnea
In a double-blind, parallel-group controlled trial, we aim to measure the effect of two weeks of light therapy combined with the CPAP on compliance CPAP in patients with major depressive disorder.
Inclusion: Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron; Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15; Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP.
Exclusion: Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months); patient wishing to choose a provider other than the protocol provider; Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP; Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators; Other psychiatric, neurologic or somatic conditions; Refusal to participate; Pregnant and breast-feeding women; Under guardianship or curatorship; Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction; Nasal obstruction.